Of course the Chat GPT dog cancer vaccine spawned a startup | The Verge
Overview
Tech Expand Amazon Apple Facebook Google Microsoft Samsung Business See all tech
Reviews Expand Smart Home Reviews Phone Reviews Tablet Reviews Headphone Reviews See all reviews
Details
Science Expand Space Energy Environment Health See all science
Entertainment Expand TV Shows Movies Audio See all entertainment
Policy Expand Antitrust Politics Law Security See all policy
Gadgets Expand Laptops Phones TVs Headphones Speakers Wearables See all gadgets
Verge Shopping Expand Buying Guides Deals Gift Guides See all shopping
Streaming Expand Disney HBONetflix You Tube Creators See all streaming
Transportation Expand Electric Cars Autonomous Cars Ride-sharing Scooters See all transportation
AIClose AIPosts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All AI
Posts from this topic will be added to your daily email digest and your homepage feed.
News Close News Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All News
Posts from this topic will be added to your daily email digest and your homepage feed.
Science Close Science Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All Science
Posts from this topic will be added to your daily email digest and your homepage feed.
Of course the Chat GPT dog cancer vaccine spawned a startup
The hyped AI-saved-my-dog story has reached its inevitable conclusion.
The hyped AI-saved-my-dog story has reached its inevitable conclusion.
Posts from this author will be added to your daily email digest and your homepage feed.
Posts from this author will be added to your daily email digest and your homepage feed.
Remember that much-hyped story about an Australian tech entrepreneur using Chat GPT, Grok, and other AI tools to craft a personalized cancer vaccine for his dog? Well, surprise: he’s launched a startup.
That entrepreneur is Paul Conyngham, who says he is launching Gamgee to offer “personalised m RNA cancer vaccines for dogs.” But his ambitions go well beyond dogs — and pets — with Gamgee’s website promising the company will harness AI and genetics to develop personalized treatments for a range of diseases and species, including humans.
At the center of Gamgee’s origin story is Rosie, Conyngham’s Staffordshire bull terrier-Shar Pei mix, who features prominently on Conyngham’s social media and the startup’s website, as well as its AI-generated anime launch video. When announcing Gamgee on X, Conyngham said “I used chatgpt + computational genomics to design a personalised m RNA cancer vaccine for her tumour. Several of her tumours shrank.”
Conyngham, who stresses on Gamgee’s website that he is “not a biologist,” credits that intervention with adding years to Rosie’s life. Gamgee’s stated mission is to do that at scale. In case the canine element is lost on its visitors, the website features a slideshow of adorable dogs alongside ages and purported cancer diagnosis to remind them “who we’re building this for.”
But as I reported for The Verge earlier this year, the science behind Rosie’s story is considerably messier than Conyngham’s neat account suggests. The exact role AI played in the endeavor wasn’t clear, and researchers said the broad claims gave the technology too much credit while minimizing the role of the humans involved. Moreover, the protocol Rosie followed made it impossible to say whether the m RNA vaccine was responsible for her improvement, since it was administered alongside another therapy.
That hasn’t stopped the idea from attracting support. The startup is backed by storied tech incubator Y Combinator and says it is recruiting for its first clinical trials in Australia, with a waitlist open everywhere else (though Conyngham says they’re “accepting cases globally.”). On a section on its website aimed at veterinarians, Gamgee touts a roughly 75 per cent tumor reduction in its “first documented case,” while promising to require less than 20 minutes of a veterinarian’s time, no new clinical workflows, and a finished “vaccine in hand” in around four weeks. The company cautions that this timeline is based on a single case and may vary. Costs aren’t disclosed on the site.
Gamgee says it’s working in collaboration with the University of Queensland and institutes at the University of New South Wales in Australia, and Conyngham encourages potential funders or study partners to reach out.
Ultimately, the company says its mission extends beyond dogs and other animals to personalized treatments for humans. For a startup built around a single dog whose improvement cannot be clearly attributed to the treatment at the core of its pitch, that’s a grand ambition.
Robert Hart Close Robert Hart AI Reporter Posts from this author will be added to your daily email digest and your homepage feed. Follow Follow See All by Robert Hart
Posts from this author will be added to your daily email digest and your homepage feed.
AIClose AIPosts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All AI
Posts from this topic will be added to your daily email digest and your homepage feed.
Health Close Health Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All Health
Posts from this topic will be added to your daily email digest and your homepage feed.
News Close News Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All News
Posts from this topic will be added to your daily email digest and your homepage feed.
Open AIClose Open AIPosts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All Open AI
Posts from this topic will be added to your daily email digest and your homepage feed.
Science Close Science Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All Science
Posts from this topic will be added to your daily email digest and your homepage feed.
Xbox Elite 3 prototype pad leaks with tiny built-in screen
Why your Amazon order confirmation emails have become so unhelpful
Google’s upcoming Pixel phones are for the fans, even if its launch event isn’t
Claude will apply invisible watermarks to AI text and images
Key Takeaways
- Tech Expand Amazon Apple Facebook Google Microsoft Samsung Business See all tech
- Reviews Expand Smart Home Reviews Phone Reviews Tablet Reviews Headphone Reviews See all reviews
- Science Expand Space Energy Environment Health See all science
- Entertainment Expand TV Shows Movies Audio See all entertainment
- Policy Expand Antitrust Politics Law Security See all policy
